Search research articles
Contact Us
Filters
Showing results (321-330 of 464) with videos related to
Page
of 47
Sort By:
The Lancet. Gastroenterology & Hepatology
|
November 16, 2025
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
Vipul Jairath, Silvio Danese, Geert R D'Haens, et al.
Gastroenterology
|
June 6, 2013
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis
William J Sandborn, Brian G Feagan, Colleen Marano, et al.
Journal of Crohn'S & Colitis
|
October 6, 2017
Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA
Simon Travis, Brian G Feagan, Laurent Peyrin-Biroulet, et al.
Inflammatory Bowel Diseases
|
April 25, 2024
Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn's Disease
Reena Khanna, Brian G Feagan, Guangyong Zou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 24, 2023
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER)
Jean-Frederic Colombel, Ryan C Ungaro, Bruce E Sands, et al.
JAMA Network Open
|
April 18, 2024
Incidence of Total Knee Arthroplasty After Arthroscopic Surgery for Knee Osteoarthritis: A Secondary Analysis of a Randomized Clinical Trial
Trevor B Birmingham, Codie A Primeau, Salimah Z Shariff, et al.
The American Journal of Gastroenterology
|
January 30, 2019
Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Robert Battat, Marjolijn Duijvestein, Leonardo Guizzetti, et al.
Gastroenterology
|
November 26, 2018
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis
William J Sandborn, Marcoli Cyrille, Mark Berner Hansen, et al.
Journal of Crohn'S & Colitis
|
March 24, 2017
Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
Maria Rosario, Jonathan L French, Nathanael L Dirks, et al.
Journal of Crohn'S & Colitis
|
February 1, 2018
Corrigendum: Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
Maria Rosario, Jonathan L French, Nathanael L Dirks, et al.
Page
of 47
Search research articles
Search
Showing results (321-330 of 464) with videos related to
Sort By:
Page
of 47
The Lancet. Gastroenterology & Hepatology
|
November 16, 2025
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
Vipul Jairath, Silvio Danese, Geert R D'Haens, et al.
Gastroenterology
|
June 6, 2013
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis
William J Sandborn, Brian G Feagan, Colleen Marano, et al.
Journal of Crohn'S & Colitis
|
October 6, 2017
Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA
Simon Travis, Brian G Feagan, Laurent Peyrin-Biroulet, et al.
Inflammatory Bowel Diseases
|
April 25, 2024
Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn's Disease
Reena Khanna, Brian G Feagan, Guangyong Zou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 24, 2023
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER)
Jean-Frederic Colombel, Ryan C Ungaro, Bruce E Sands, et al.
JAMA Network Open
|
April 18, 2024
Incidence of Total Knee Arthroplasty After Arthroscopic Surgery for Knee Osteoarthritis: A Secondary Analysis of a Randomized Clinical Trial
Trevor B Birmingham, Codie A Primeau, Salimah Z Shariff, et al.
The American Journal of Gastroenterology
|
January 30, 2019
Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Robert Battat, Marjolijn Duijvestein, Leonardo Guizzetti, et al.
Gastroenterology
|
November 26, 2018
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis
William J Sandborn, Marcoli Cyrille, Mark Berner Hansen, et al.
Journal of Crohn'S & Colitis
|
March 24, 2017
Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
Maria Rosario, Jonathan L French, Nathanael L Dirks, et al.
Journal of Crohn'S & Colitis
|
February 1, 2018
Corrigendum: Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
Maria Rosario, Jonathan L French, Nathanael L Dirks, et al.
Page
of 47